YARW（YARW）價格預測YARWYARW

Yarrow Bioscience Inc is a good buy right now due to its recent FDA Fast Track designation for YB-101, which positions it favorably in the market, and an analyst price target of $58, indicating a potential upside of approximately 92% from the current price of $30.21. The company has a strong gross margin of 100%, reflecting its potential for profitability once it scales operations, despite current net income losses.

(YARW) last closed at $30.21, gaining +4.71%. These facts feed the 1-day and 1-week YARW price prediction above.